Antiparkinsonian treatment in pregnancy

被引：18

作者：

De Mari, M ^{[1
]}

Zenzola, A ^{[1
]}

Lamberti, P ^{[1
]}

机构：

[1] Univ Bari, Dept Neurol Sci, Bari, Italy

来源：

MOVEMENT DISORDERS | 2002年 / 17卷 / 02期

关键词：

D O I：

10.1002/mds.10040

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：428 / 429

页数：2

共 16 条

[1] PREGNANCY AND PARKINSONISM - A CASE-REPORT WITHOUT PROBLEM [J].

ALLAIN, H ;

BENTUEFERRER, D ;

MILON, D ;

MORAN, P ;

JACQUEMARD, F ;

DEFAWE, G .

CLINICAL NEUROPHARMACOLOGY, 1989, 12 (03) :217-219

[2]

Benito-León J, 1999, MOVEMENT DISORD, V14, P194, DOI 10.1002/1531-8257(199901)14:1<194::AID-MDS1044>3.0.CO

[3]

2-S

[4] DEVELOPMENTAL TOXICITY OF THE DOPAMINE AGONIST PERGOLIDE MESYLATE IN CD-1 MICE .1. GESTATIONAL EXPOSURE [J].

BUELKESAM, J ;

BYRD, RA ;

JOHNSON, JA ;

TIZZANO, JP ;

OWEN, NV .

NEUROTOXICOLOGY AND TERATOLOGY, 1991, 13 (03) :283-295

[5] DEVELOPMENTAL TOXICITY OF THE DOPAMINE AGONIST PERGOLIDE MESYLATE IN CD-1 MICE .2. PERINATAL AND POSTNATAL EXPOSURE [J].

BUELKESAM, J ;

COHEN, IR ;

TIZZANO, JP ;

OWEN, NV .

NEUROTOXICOLOGY AND TERATOLOGY, 1991, 13 (03) :297-306

[6] LEVODOPA DURING PREGNANCY [J].

COOK, DG ;

KLAWANS, HL .

CLINICAL NEUROPHARMACOLOGY, 1985, 8 (01) :93-95

[7]

FISHMAN J, 1981, J ENDOCRINOL S, V89, P59

[8] Pregnancy in Parkinson's disease: A review of the literature and a case report [J].

Hagell, P ;

Odin, P ;

Vinge, E .

MOVEMENT DISORDERS, 1998, 13 (01) :34-38

[9]

NORA J, 1975, LANCET, V2, P167

[10]

Routiot T, 2000, J Gynecol Obstet Biol Reprod (Paris), V29, P454

← 1 2 →